Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses.

[1]  M. Schubert,et al.  Treatment of gastric carcinoids , 2007, Current treatment options in gastroenterology.

[2]  M. Burkitt,et al.  Review article: pathogenesis and management of gastric carcinoid tumours , 2006, Alimentary pharmacology & therapeutics.

[3]  G. Capurso,et al.  Endocrine tumours of the stomach. , 2005, Best practice & research. Clinical gastroenterology.

[4]  L. Grimelius,et al.  Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type , 2005, Annals of surgery.

[5]  J. Norton,et al.  Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. , 2004, Surgery.

[6]  I. Modlin,et al.  A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem? , 2004, American Journal of Gastroenterology.

[7]  S. Falkmer,et al.  Treatment of ECL cell carcinoids with octreotide LAR , 2004 .

[8]  I. Modlin,et al.  Carcinoid tumors of the stomach. , 2003, Surgical oncology.

[9]  I. Modlin,et al.  A 5‐decade analysis of 13,715 carcinoid tumors , 2003, Cancer.

[10]  L. Gullo,et al.  Treatment of type II gastric carcinoid tumors with somatostatin analogues. , 2000, The New England journal of medicine.

[11]  C. Capella,et al.  Morphological, molecular, and prognostic aspects of gastric endocrine tumors , 2000, Microscopy research and technique.

[12]  M. Stolte,et al.  ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. , 1999, Gastroenterology.

[13]  M. Brandi,et al.  Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. , 1997, The American journal of surgical pathology.

[14]  C. Bordi,et al.  Neuroendokrine Tumoren des Magens Pathogenese, Klassifikation und Klinik* , 1997, Der Pathologe.

[15]  C. Bordi,et al.  [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects]. , 1997, Der Pathologe.

[16]  G. Åkerström.  Management of Carcinoid Tumors of the Stomach, Duodenum, and Pancreas , 1996, World Journal of Surgery.

[17]  M. Stolte,et al.  Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior , 1996, World Journal of Surgery.

[18]  G. delle Fave,et al.  Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  C. Bordi.  Endocrine tumours of the stomach. , 1995, Pathology, research and practice.

[20]  A. West,et al.  Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. , 1995, The American journal of gastroenterology.

[21]  L. Sobin,et al.  Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients , 1994, Cancer.

[22]  O. Luinetti,et al.  Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. , 1993, Gastroenterology.

[23]  A. Miwa,et al.  Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. , 1991, The American journal of gastroenterology.

[24]  J. Godwin.  Carcinoid Tumors An analysis of 2837 cases , 1975, Cancer.

[25]  M. Stolte,et al.  Prognosis of gastric carcinoid tumours. , 1995, Digestion.